ArticlePediatric surgery international2025
Intratesticular and peritesticular methylene blue injection in visualizing lymphatic vessels and its impact on testicular injury in rat testes.
Article in Pediatric surgery international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveMethylene blue is a vital dye used for lymphatic mapping in laparoscopic varicocelectomy. However, some clinical studies have reported testicular calcifications following its use, raising concerns about its potential impact on testicular health. We aimed to experimentally investigate the pathological changes associated with the application of different concentrations of methylene blue through both intratesticular and peritesticular routes. MATERIALS AND
methodsThis study examined methylene blue-induced testicular damage in 45 male Wistar albino rats. Rats were divided into seven groups and received intratesticular or peritesticular injections: control (G1), saline (G2), needle-only (G3), methylene blue 100% intratesticular (G4), methylene blue 50% intratesticular (G5), methylene blue 100% peritesticular (G6), and methylene blue 50% peritesticular (G7). Testicular tissues were histologically analyzed for structural changes, including edema, inflammation, calcification, hyalinization and spermatogenesis alterations, using hematoxylin-eosin staining and Johnsen scoring.
resultsHistopathological analysis showed significant testicular changes. Hyalinization was absent in G1-G3 but present in G4 (28.6%), G5 (35.7%), and G6 (35.7%) (p = 0.001). Calcification peaked in G4 (50%) and G5 (42.9%) (p = 0.004). Seminiferous tubule necrosis (ST necrosis) was highest in G4 (28.6%) and G5 (21.4%) (p = 0.027). Tubular atrophy was most severe in G5 (42.9%) (p = 0.011). Inflammation and edema were prominent in G4 (42.9%), G5 (35.7%), and G6 (100%) (p < 0.001). Two-way ANOVA indicated significant differences between testicular sides (p < 0.001). Peritesticular injection caused milder changes.
conclusionIntratesticular methylene blue injection, especially at high concentrations, caused significant testicular damage, including calcification, tubular atrophy, ST necrosis, and hyalinization.
Indexed as
Identifiers
40515842What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.